Drug intelligence / Profile preview

chicken tallow

Development stage: Preclinical
Modality: Small Molecules
Administration: Vaginal

Overview

Chicken tallow is a natural product used as an ingredient in a vaginal cream formulation. This product was investigated for its effectiveness in treating subjective symptoms of vulvovaginal atrophy (VVA) in women with breast cancer, particularly those experiencing menopause induced by chemical drugs. It is considered a non-hormonal alternative to existing treatments like estrogen compounds, which can have undesired side effects.

Beyond the preview

Go deeper on chicken tallow.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on chicken tallow.

Explore the full profile